# Contrast-Enhanced Ultrasound for Kidney Transplant

> **NCT02911714** · PHASE1 · TERMINATED · sponsor: **University of Utah** · enrollment: 20 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Lumason Contrast-Enhanced Ultrasound

## Key facts

- **NCT ID:** NCT02911714
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-21
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02911714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02911714, "Contrast-Enhanced Ultrasound for Kidney Transplant". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02911714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*